logo
Select company
Select metric
Ticker Information

Ticker

EBS

Company Name

EMERGENT BIOSOLUTIONS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NYSE

EMERGENT BIOSOLUTIONS INC - Capital Expenditures Coverage Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EBS - CapEx Coverage Historical data
DateCapital ExpenditureCapital Expenditures CoverageNet Cash Flow - Operations
6/30/2025$ -32.1M0$ 169M
3/31/2025$ -30.3M0$ 110.1M
12/31/2024$ 15M3.91$ 58.7M
9/30/2024$ 25M6.83$ 170.7M
6/30/2024$ 39.4M1.95$ 77M
3/31/2024$ 47.3M0$ -84.9M
12/31/2023$ 51.6M0$ -206.3M
9/30/2023$ 63.8M0$ -145.6M
6/30/2023$ 79.1M0$ -279.6M
3/31/2023$ 98.7M0$ -180.8M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EMERGENT BIOSOLUTIONS INC's latest trailing twelve months (TTM) CapEx Coverage stands at 2.93.
  • Over the past 5 years, EMERGENT BIOSOLUTIONS INC's average CapEx Coverage has been 2.58.
  • The median CapEx Coverage for EMERGENT BIOSOLUTIONS INC during this period was 1.86
  • EMERGENT BIOSOLUTIONS INC reached its highest CapEx Coverage over the past 5 years at 6.83.
  • The lowest CapEx Coverage recorded by EMERGENT BIOSOLUTIONS INC in the same timeframe 1.11

EMERGENT BIOSOLUTIONS INC's CapEx Coverage vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Coverage Benchmarks
CompanyCapEx Coverage
OFIX : ORTHOFIX MEDICAL INC 1.02ESPR : ESPERION THERAPEUTICS INC -ORGO : ORGANOGENESIS HOLDINGS INC -MYGN : MYRIAD GENETICS INC -AVNS : AVANOS MEDICAL INC 4.45SIGA : SIGA TECHNOLOGIES INC 1.83KVREX : VAREX IMAGING CORP 2.56EHAB : ENHABIT INC 15.09INNV : INNOVAGE HOLDING CORP 5.25EOLS : EVOLUS INC -

Definition of Capital Expenditures Coverage

[Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
CF - Operations / CapEx
(=) CapEx Coverage
CapEx Coverage for EMERGENT BIOSOLUTIONS INC is calculated as follows: CF - Operations [ $ 413M ] / CapEx [ $ 141.1M ]
(=) CapEx Coverage [ 2.93 ]

EBS - Capital Expenditures Coverage, Last 5 years

1.11

Minimum

Sep 30, 2021

6.83

Maximum

Sep 30, 2024

2.58

Average

1.86

Median

CapEx Coverage Benchmark Analysis

The chart above depicts the distribution of CapEx Coverage for companies in the Total Stock Market. The average CapEx Coverage of the companies is 4.42 with a standard deviation of 4.02.
The following table provides additional summary stats:
CapEx Coverage in the Market:
filtered constituents2.21K
min0.01
max17.91
average4.42
median3.01
std4.02